Company intelligence / Profile preview

Wuxi Reba Bestplus Technology

Ownership: Private
Development stage: Other

Overview

Wuxi Reba Bestplus Technology is a biotechnology company based in Wuxi, China, specializing in high-end chemical synthesis and contract research services. The company focuses on providing specialized building blocks, intermediates, and custom synthesis solutions for the pharmaceutical and life sciences industries. Their expertise spans small molecule drug discovery, peptide synthesis, and the development of complex organic compounds. Reba Bestplus serves as a strategic partner for global biotech and pharma companies, offering technical support from early-stage R&D through to pilot-scale production.

Modalities: Small moleculePeptidesOligonucleotide
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Wuxi Reba Bestplus Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuxi Reba Bestplus Technology.